Patient-Centered Pathways for Advancing Cancer Care

02.14.14 | By

There's been a lot of discussion lately about the need to control rising health care costs, and the role of new medicines and medical technology. Nowhere has this discussion been sharper than in the area of oncology. At PhRMA, we’ve been joining in many of these discussions, working with other stakeholders to identify solutions to sustain continued progress and support efficient delivery of optimal patient care.

Importance of Keeping Patients Informed

02.14.14 | By

Within the medical community there is so much truth to the saying, “knowledge is power.” Whether it’s sharing information about a new medicine in development that could save a patient’s life, or sharing resources and ideas to change a patient’s life, it is essential that patients, doctors, and other members of the health care ecosystem stay well informed and disseminate their knowledge.

It’s Valentine’s Day, Have a Heart

02.14.14 | By

It’s no coincidence that February is American Heart Month and host to Valentine’s Day, and as a result, there is no better time to focus on your heart.

Fighting Prescription Drug Abuse

02.11.14 | By

With the tragic news of Philip Seymour Hoffman’s death, the national conversation around addiction has gained a new focal point. Though Hoffman died from a heroin overdose, his death has intensified an ongoing discussion about the abuse and misuse of painkillers and other medicines. 

Nearly 200 New Medicines in Development for Diabetes

Washington, D.C. (February 11, 2014) — America’s biopharmaceutical research companies currently are developing 180 innovative new medicines to help the nearly 400 million people who have diabetes worldwide.

Why Intellectual Property Matters for Patients

02.11.14 | By

The importance of protecting intellectual property cannot be overstated. For the biopharmaceutical industry, ensuring our ability to innovate is essential for continued R&D to help patients live longer, healthier lives.

The Ongoing Battle for Patient Health

02.07.14 | By

Every day there is a war to wage against the world’s most devastating diseases. It is a fight we must win to make the world a safer, healthier place for our patients, and this week we discussed some of the battles currently underway.

Intellectual Property Protection and India

02.06.14 | By

A new study  examines the economic impact of India’s current approach to intellectual property rights as it affects pharmaceutical products and Foreign Direct Investment (FDI).  The study from Sonecon by Robert Shapiro and Aparna Mathur titled “How India Can Attract More Foreign Direct Invest Investment, Create Jobs, and Increase GDP: The Benefits of Respecting the Intellectual Property Rights of Foreign Pharmaceutical Producers” establishes that i

Briefing Assesses Impact of U.S. v. Caronia Ruling on Regulation of Medical Communications, One Year Later

01.31.14 | By

 The Washington Legal Foundation recently convened an enlightening expert roundtable discussion about the impact of late 2012's decision in U.S. vs. Caronia. 

Commitment to Data Sharing

01.30.14 | By

As of January 1, researchers are now able to submit proposals to receive access to patient level data, protocols, and clinical study reports for new medicines approved in the U.S and EU after January 1, 2014.  The biopharmaceutical sector’s commitment to data sharing provides new avenues for the scientific community and patients to benefit from clinical research, while maintaining patient privacy, the integrity of national regulators, and incentives for companies to make long-term investments in biomedical research.
 

Pages

Subscribe to RSS - Opinion